Personalised structural connectomics for moderate-to-severe traumatic brain injury

Phoebe Imms; Adam Clemente; Evelyn Deutscher; Ahmed M. Radwan; Hamed Akhlaghi; Paul Beech; Peter H Wilson; Andrei Irimia; Govinda Poudel; Juan F Domínguez D; Karen Caeyenberghs

doi:10.1101/2022.03.02.22271654

Abstract

Graph theoretical analysis of the structural connectome has been employed successfully to characterise brain network alterations in patients with traumatic brain injury (TBI). However, heterogeneity in neuropathology is a well-known issue in the TBI population, such that group comparisons of patients against controls are confounded by within-group variability. Recently, novel single-subject profiling approaches have been developed to capture inter-patient heterogeneity. We present a personalised connectomics approach that examines structural brain alterations in six chronic patients with moderate-to-severe TBI who underwent anatomical and diffusion magnetic resonance imaging (MRI). We generated individualised profiles of lesion characteristics and network measures (including personalised graph metric ‘GraphMe’ plots, and nodal and edge-based brain network alterations) and compared them against healthy reference cases (N=12) to assess brain damage qualitatively and quantitatively at the individual level. Our findings revealed clinically significant alterations of brain networks with high variability between patients. Our profiling can be used by clinicians to formulate a neuroscience-guided integrative rehabilitation program for TBI patients, and for designing personalised rehabilitation protocols based on their unique lesion load and connectome.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by an Australian Catholic University Research Fund [#902915].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was granted by the St Vincents Hospital Melbourne ethics committee for human research (project #250/17).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes